Rational individualised selection of adjuvant therapy for ductal carcinoma in situ.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Rapid Diagnosis of Ductal Carcinoma In Situ and Breast Cancer Based on Raman Spectroscopy of Serum Combined with Convolutional Neural Network.Bioengineering (Basel, Switzerland) · 2023
   Article
2. Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?Breast cancer research and treatment · 2021
   Article
3. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.Breast cancer research : BCR · 2019
   Article
4. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.European radiology · 2019
   Article
5. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.Journal of Cancer · 2017
   Review
6. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.Breast cancer research and treatment · 2013
   Article
7. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.Breast cancer research and treatment · 2012
   Article
8. Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.Journal of Cancer · 2011
   Article

Corrections and comments

• Comment on
  Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as